2017 is a prime number, but that’s certainly not the only thing that made last year unique. Read the Commonwealth Fund’s new annual report, “The Year in Numbers,” for highlights from our recent work. Also read Commonwealth Fund President David Blumenth…
In the journal Academic Medicine, the Commonwealth Fund’s David Blumenthal, M.D., Douglas McCarthy, and Tanya Shah issue a call to action for academic medical centers to “accelerate the path to improving care for the country’s sickest and most expensiv…
Join a July 12 webinar from 2 pm to 3 pm, E.T., to hear from KPMG and the Commonwealth Fund about a new guide to help health care organizations develop the business case for investing in social service and obtain measurable returns on investment.
…
Earlier this month, oral arguments began in a class action lawsuit brought by 15 Kentucky Medicaid beneficiaries that challenges the legality of the state’s attempt to make employment or community service a requirement for Medicaid eligibility. In a ne…
At age 48, Robin Ridley of Goodlettsville, Tenn., was diagnosed with multiple myeloma, a blood cancer that affects the plasma cells found in bone marrow. Starting next year, Robin’s COBRA coverage and the drug manufacturer support she now receives for …
In a Commonwealth Fund-supported study in Health Affairs, Benjamin Sommers, M.D., and colleagues at the Harvard T. H. Chan School of Public Health surveyed low-income adults in three Midwestern states with different Medicaid policies: Indiana, which us…
Several states are moving forward with plans to implement state-level individual health insurance mandates in light of Congress’s recent elimination of the ACA’s federal mandate penalty, effective in 2019. In a new To the Point post, Georgetown Univers…
The recent court ruling allowing the merger of AT&T and Time Warner will likely encourage similar unions throughout the U.S. economy, including in health care. But policymakers and private actors should not interpret the court’s decision as an uncondit…
Pharmaceutical companies argue that high prices are necessary to support innovation. Yet Commonwealth Fund President David Blumenthal, M.D., in a new Experts blog in the Wall Street Journal (subscription required), says this justification raises other …
